144 related articles for article (PubMed ID: 34168564)
1. Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE.
Farghaly MN; Al Dallal SAM; Fasseeh AN; Monsef NA; Suliman EAMA; Tahoun MA; Abaza S; Kaló Z
Front Pharmacol; 2021; 12():680737. PubMed ID: 34168564
[No Abstract] [Full Text] [Related]
2. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
Inotai A; Brixner D; Maniadakis N; Dwiprahasto I; Kristin E; Prabowo A; Yasmina A; Priohutomo S; Németh B; Wijaya K; Kalo Z
BMC Health Serv Res; 2018 Dec; 18(1):1003. PubMed ID: 30594250
[TBL] [Abstract][Full Text] [Related]
3. Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait.
Abdullah AH; Holtorf AP; Al-Hussaini M; Lemay J; Alowayesh M; Kaló Z
J Pharm Policy Pract; 2019; 12():9. PubMed ID: 31011430
[TBL] [Abstract][Full Text] [Related]
4. A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Elezbawy B; Fasseeh AN; Sedrak A; Eldessouki R; Gamal M; Eldebeiky M; Amer H; Akeel S; Morsy A; Amin A; Shafik A; Abaza S; Kaló Z
J Pharm Policy Pract; 2022 Mar; 15(1):10. PubMed ID: 35232487
[TBL] [Abstract][Full Text] [Related]
5. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
[TBL] [Abstract][Full Text] [Related]
6. Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs.
Alnaqbi KA; Elezbawy B; Fasseeh AN; Bangash AR; Elshamy A; Shendi H; Aftab MI; AlMarshoodi M; Gebran N; AlDhaheri N; Fahmy SA; Al Dallal S; Al Naeem W; Abaza S; Kaló Z
Cureus; 2024 Feb; 16(2):e55215. PubMed ID: 38558740
[TBL] [Abstract][Full Text] [Related]
7. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
8. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
[TBL] [Abstract][Full Text] [Related]
9. An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets.
Brixner D; Kaló Z; Maniadakis N; Kim K; Wijaya K
Value Health Reg Issues; 2018 Sep; 16():9-13. PubMed ID: 29605800
[TBL] [Abstract][Full Text] [Related]
10. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
11. A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt.
Elezbawy B; Fasseeh AN; Németh B; Gamal M; Eldebeiky M; Refaat R; Taha A; Rabiea S; Abdallah M; Ramadan S; Noaman H; Eldin AB; Mostafa H; Nouh S; Zaki A; Abdelrahman M; Abaza S; Kalò Z
BMC Med Inform Decis Mak; 2022 Nov; 22(1):289. PubMed ID: 36352382
[TBL] [Abstract][Full Text] [Related]
12. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
Angelis A; Kanavos P
Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
[TBL] [Abstract][Full Text] [Related]
13. Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand.
Holtorf AP; Kristin E; Assamawakin A; Upakdee N; Indrianti R; Apinchonbancha N
J Pharm Policy Pract; 2021 Jun; 14(1):52. PubMed ID: 34127071
[TBL] [Abstract][Full Text] [Related]
14. Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States.
Mendola ND; Oehrlein E; Perfetto EM; Westrich K; McQueen RB
J Manag Care Spec Pharm; 2022 Oct; 28(10):1190-1196. PubMed ID: 36125060
[No Abstract] [Full Text] [Related]
15. Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.
Angelis A
MDM Policy Pract; 2018; 3(2):2381468318796218. PubMed ID: 35187241
[No Abstract] [Full Text] [Related]
16. Developing a Multi-Criteria Decision Analysis Tool to Support the Adoption of Evidence-Based Child Maltreatment Prevention Programs.
Cruden G; Frerichs L; Powell BJ; Lanier P; Brown CH; Lich KH
Prev Sci; 2020 Nov; 21(8):1059-1064. PubMed ID: 33040271
[TBL] [Abstract][Full Text] [Related]
17. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
[TBL] [Abstract][Full Text] [Related]
18. Early Access to Medicines: Use of Multicriteria Decision Analysis (MCDA) as a Decision Tool in Catalonia (Spain).
Gasol M; Paco N; Guarga L; Bosch JÀ; Pontes C; Obach M
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268443
[TBL] [Abstract][Full Text] [Related]
19. Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study.
Goetghebeur MM; Wagner M; Nikodem M; Zyla A; Micaleff A; Amzal B
Ther Innov Regul Sci; 2016 Sep; 50(5):620-631. PubMed ID: 30231761
[TBL] [Abstract][Full Text] [Related]
20. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
